| Literature DB >> 30905230 |
Dominika Kanikowska1, Alina Kanikowska2, Rafał Rutkowski1, Małgorzata Włochal2, Zofia Orzechowska1, Aldona Juchacz2, Agnieszka Zawada2, Marian Grzymisławski2, Magdalena Roszak3, Maki Sato4, Andrzej Bręborowicz1, Janusz Witowski1.
Abstract
CONTEXT: Amaranth and canola oils have been used traditionally. Amaranth has been identified as being of interest because of its outstanding nutritive value. Amaranth oil is a rich source of highly unsaturated fats and so could be a valuable dietary alternative for individuals affected with obesity. Reactive oxygen species (ROS) are postulated to be involved in systemic inflammation and oxidative stress. Activated polymorphonuclear neutrophils (PMNs) generate high amounts of reactive oxygen species.Entities:
Keywords: Neutrophil oxidative burst; obesity; plant oil
Mesh:
Substances:
Year: 2019 PMID: 30905230 PMCID: PMC6442228 DOI: 10.1080/13880209.2019.1569696
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Figure 1.Study protocol.
Figure 2.The oxidative burst of neutrophils from obese subjects before and after dietary treatment. The results were expressed as the fluorescence intensity (IF) ratio. ±SD. p < 0.05.
Figure 3.The effect of dietary treatment of canola oil on oxidative burst of neutrophils. The oxidative burst of neutrophils before and after canola oil treatment. The results were expressed as the fluorescence intensity (IF) ratio. ±SD. p < 0.05.
Figure 4.The effect of dietary treatment of amaranth oil on oxidative burst of neutrophils. The oxidative burst of neutrophils before and after amaranth oil treatment. The results were expressed as the fluorescence intensity (IF) ratio. ±SD. p > 0.05 (not significant).
Characteristics of the subjects in the two intervention groups (n 19). Between-group comparisons were performed using Student’s t-test with significance established at *p < 0.005.
| Canola oil ( | Amaranth oil ( | |||
|---|---|---|---|---|
| Baseline | After 3 weeks | Baseline | After 3 weeks | |
| Age (years) (±SD) | 51.1 (18.02) | 43.9 (11.16) | ||
| Height (cm) (±SD) | 177.6 (7.42) | 171.3 (9.01) | ||
| Weight (kg) (±SD) | 126.2 (15.89) | 120.5* (15.7) | 126.6 (27.66) | 118.8* (24.7) |
| BMI (kg/m2) (±SD) | 39.9 (4.03) | 38.7 (4.8) | 42.9 (10.39) | 40.3 (9.9) |
| Waist/hip ratio (±SD) | 1.0 (0.10) | 1.01* (0.1) | 0.9 (0.1) | 0.9 (0.1) |
| Body fat mass (kg) (± (9.7) | 49.4 (14.0) | 45.7 (19.2) | ||
| Fat free mass (± SD) | 78.45 (8.8) | 75.79* (9.5) | 76.56 (16.1) | 71.6 (11.2) |
| Basal metabolic rate (± SD) | 2402.182 (309.33) | 2312.364* (302.93) | 2378.1 (547.8) | 2210 (382.0) |